226 related articles for article (PubMed ID: 35593979)
1. The barriers and facilitators to satisfaction with botulinum neurotoxin treatment in people with cervical dystonia: a systematic review.
Boyce MJ; McCambridge AB; Bradnam LV; Canning CG; Verhagen AP
Neurol Sci; 2022 Aug; 43(8):4663-4670. PubMed ID: 35593979
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin and conservative treatment strategies in people with cervical dystonia: an online survey.
Boyce MJ; McCambridge AB; Bradnam LV; Canning CG; De Oliveira CQ; Verhagen AP
J Neural Transm (Vienna); 2024 Jan; 131(1):43-51. PubMed ID: 37831150
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type B for cervical dystonia.
Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin therapy for cervical dystonia.
Jankovic J
Neurotox Res; 2006 Apr; 9(2-3):145-8. PubMed ID: 16785112
[TBL] [Abstract][Full Text] [Related]
5. Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Costs Among Patients with Spasticity or Cervical Dystonia in the US.
Hull M; Anupindi VR; DeKoven M; He J; Bouchard J
Adv Ther; 2023 Sep; 40(9):3986-4003. PubMed ID: 37414904
[TBL] [Abstract][Full Text] [Related]
6. Spectral EMG Changes in Cervical Dystonia Patients and the Influence of Botulinum Toxin Treatment.
Nijmeijer SWR; de Bruijn E; Verhagen R; Forbes PA; Kamphuis DJ; Happee R; Tijssen MAJ; Koelman JHTM
Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28832550
[TBL] [Abstract][Full Text] [Related]
7. KinesioTaping after botulinum toxin type A for cervical dystonia in adult patients.
Dec-Ćwiek M; Porębska K; Sawczyńska K; Kubala M; Witkowska M; Zmijewska K; Antczak J; Pera J
Brain Behav; 2022 Apr; 12(4):e2541. PubMed ID: 35238494
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
Pappert EJ; Germanson T;
Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
[TBL] [Abstract][Full Text] [Related]
9. INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin.
Misra VP; Colosimo C; Charles D; Chung TM; Maisonobe P; Om S;
J Neurol; 2018 Feb; 265(2):402-409. PubMed ID: 29270685
[TBL] [Abstract][Full Text] [Related]
10. Cervical dystonia: factors deteriorating patient satisfaction of long-term treatment with botulinum toxin.
Marciniec M; Szczepańska-Szerej A; Rejdak K
Neurol Res; 2020 Nov; 42(11):987-991. PubMed ID: 32693754
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?
Jinnah HA; Comella CL; Perlmutter J; Lungu C; Hallett M;
Toxicon; 2018 Jun; 147():89-95. PubMed ID: 28888929
[TBL] [Abstract][Full Text] [Related]
12. Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review.
Erro R; Picillo M; Pellecchia MT; Barone P
Toxins (Basel); 2023 Jun; 15(6):. PubMed ID: 37368692
[TBL] [Abstract][Full Text] [Related]
13. Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment.
Camargo CH; Cattai L; Teive HA
Toxins (Basel); 2015 Jun; 7(6):2321-35. PubMed ID: 26110508
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: a systematic review.
Colosimo C; Tiple D; Berardelli A
Neurotox Res; 2012 Nov; 22(4):265-73. PubMed ID: 22359151
[TBL] [Abstract][Full Text] [Related]
15. The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia.
Hefter H; Schomaecker I; Schomaecker M; Rosenthal D; Samadzadeh S
Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357965
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.
Costa J; Borges A; Espírito-Santo C; Ferreira J; Coelho M; Moore P; Sampaio C
Cochrane Database Syst Rev; 2005 Jan; (1):CD004314. PubMed ID: 15674940
[TBL] [Abstract][Full Text] [Related]
17. Changes in sensorimotor network activation after botulinum toxin type A injections in patients with cervical dystonia: a functional MRI study.
Nevrlý M; Hluštík P; Hok P; Otruba P; Tüdös Z; Kaňovský P
Exp Brain Res; 2018 Oct; 236(10):2627-2637. PubMed ID: 29971454
[TBL] [Abstract][Full Text] [Related]
18. Study protocol: multimodal physiotherapy as an add-on treatment to botulinum neurotoxin type A therapy for patients with cervical dystonia: DysPT-multi-a prospective, multicentre, single-blind, randomized, controlled study.
Werner C; Loudovici-Krug D; Derlien S; Rakers F; Smolenski UC; Lehmann T; Best N; Günther A
Trials; 2021 Oct; 22(1):740. PubMed ID: 34696821
[TBL] [Abstract][Full Text] [Related]
19. Adverse events with botulinum toxin treatment in cervical dystonia: How much should we blame placebo?
Duarte GS; Rodrigues FB; Ferreira JJ; Costa J
Parkinsonism Relat Disord; 2018 Nov; 56():16-19. PubMed ID: 29910156
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in long-term botulinum toxin treatment of cervical dystonia: Results of a cross sectional study.
Moll M; Rosenthal D; Hefter H
Parkinsonism Relat Disord; 2018 Dec; 57():63-67. PubMed ID: 30150129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]